Fungal Supplement May Reduce COVID-19 Vaccine Adverse Effects and Extend Antibody Protection
• Researchers at UC San Diego School of Medicine found that a 4-day course of a mycelium-based fungal supplement reduced adverse reactions in COVID-naive vaccine recipients. • According to a double-blind, placebo-controlled trial (NCT04951336) published in BMC Immunology, the supplement also helped sustain antibody levels for up to 6 months. • These findings are significant as they could improve vaccine tolerability and help reduce vaccine hesitancy among the general population.
pharmacytimes.com









